Prognostic value of the platelet-to-lymphocyte ratio in lung cancer patients receiving immunotherapy: A systematic review and meta-analysis

• Published in: PloS one Vol. 17; no. 5; p. e0268288
• Main Authors: Wang, Haoyu, Li, Cui, Yang, Ruiyuan, Jin, Jing, Liu, Dan, Li, Weimin
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 06.05.2022; Public Library of Science (PLoS)
• Subjects: Bias; Biology and Life Sciences; Biomarkers; Cancer therapies; Complications and side effects; Confidence intervals; Ethnicity; Immunotherapy; Lung cancer; Lung diseases; Lymphocytes; Medical ethics; Medical prognosis; Medicine and Health Sciences; Meta-analysis; Patient outcomes; Patients; Physical Sciences; Platelets; Prognosis; Research and Analysis Methods; Sample size; Science Policy; Sensitivity analysis; Statistical analysis; Subgroups; Survival; Systematic review; China

Current studies have revealed that the platelet to lymphocyte ratio (PLR) may lead to a poor prognosis in lung cancer patients receiving immunotherapy. We conducted a meta-analysis to explore the prognostic value of PLR in lung cancer patients receiving immunotherapy. We retrieved potential studies...